CN102228613A - Chinese patent medicine for treating tinea capitis - Google Patents
Chinese patent medicine for treating tinea capitis Download PDFInfo
- Publication number
- CN102228613A CN102228613A CN2011101565922A CN201110156592A CN102228613A CN 102228613 A CN102228613 A CN 102228613A CN 2011101565922 A CN2011101565922 A CN 2011101565922A CN 201110156592 A CN201110156592 A CN 201110156592A CN 102228613 A CN102228613 A CN 102228613A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- root
- chinese patent
- patent medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 57
- 206010043866 Tinea capitis Diseases 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 claims description 16
- 229940079593 drug Drugs 0.000 claims description 14
- 241000219198 Brassica Species 0.000 claims description 13
- 235000003351 Brassica cretica Nutrition 0.000 claims description 13
- 235000003343 Brassica rupestris Nutrition 0.000 claims description 13
- 241000903946 Clematidis Species 0.000 claims description 13
- 241000628997 Flos Species 0.000 claims description 13
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 13
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 claims description 13
- 235000010460 mustard Nutrition 0.000 claims description 13
- 241000255791 Bombyx Species 0.000 claims description 12
- 241000245240 Lonicera Species 0.000 claims description 12
- 241000207929 Scutellaria Species 0.000 claims description 12
- 238000005516 engineering process Methods 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 6
- 239000003826 tablet Substances 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 11
- 201000010099 disease Diseases 0.000 abstract description 9
- 230000001737 promoting effect Effects 0.000 abstract description 9
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract description 2
- 244000170916 Paeonia officinalis Species 0.000 abstract 2
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 2
- 240000005748 Achyranthes aspera Species 0.000 abstract 1
- 235000005517 Achyranthes aspera Nutrition 0.000 abstract 1
- 241001633583 Adenophora Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000255789 Bombyx mori Species 0.000 abstract 1
- 241000050051 Chelone glabra Species 0.000 abstract 1
- 244000192528 Chrysanthemum parthenium Species 0.000 abstract 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000218158 Clematis Species 0.000 abstract 1
- 241000123589 Dipsacus Species 0.000 abstract 1
- 235000006439 Lemna minor Nutrition 0.000 abstract 1
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 abstract 1
- 240000002948 Ophiopogon intermedius Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 241000951473 Schizonepeta Species 0.000 abstract 1
- 241000913745 Spatholobus Species 0.000 abstract 1
- 230000009323 psychological health Effects 0.000 abstract 1
- 208000017520 skin disease Diseases 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 34
- 210000004369 blood Anatomy 0.000 description 30
- 230000000694 effects Effects 0.000 description 24
- 208000002474 Tinea Diseases 0.000 description 18
- 241000130764 Tinea Species 0.000 description 18
- 210000004185 liver Anatomy 0.000 description 15
- 208000002193 Pain Diseases 0.000 description 14
- 230000006870 function Effects 0.000 description 11
- 210000004072 lung Anatomy 0.000 description 11
- 210000000952 spleen Anatomy 0.000 description 11
- 235000009508 confectionery Nutrition 0.000 description 10
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- 230000017531 blood circulation Effects 0.000 description 9
- 206010007247 Carbuncle Diseases 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 206010040882 skin lesion Diseases 0.000 description 8
- 231100000444 skin lesion Toxicity 0.000 description 8
- 208000003251 Pruritus Diseases 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 208000009189 tinea favosa Diseases 0.000 description 7
- 201000000736 Amenorrhea Diseases 0.000 description 6
- 206010001928 Amenorrhoea Diseases 0.000 description 6
- 208000006820 Arthralgia Diseases 0.000 description 6
- 231100000540 amenorrhea Toxicity 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 208000011580 syndromic disease Diseases 0.000 description 6
- 238000005303 weighing Methods 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 210000003128 head Anatomy 0.000 description 5
- 239000012567 medical material Substances 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 206010037844 rash Diseases 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 208000004998 Abdominal Pain Diseases 0.000 description 4
- 208000010201 Exanthema Diseases 0.000 description 4
- 208000019255 Menstrual disease Diseases 0.000 description 4
- 206010040943 Skin Ulcer Diseases 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 201000005884 exanthem Diseases 0.000 description 4
- 230000004630 mental health Effects 0.000 description 4
- 238000000386 microscopy Methods 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 231100000019 skin ulcer Toxicity 0.000 description 4
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 208000008454 Hyperhidrosis Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 238000003759 clinical diagnosis Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 210000003238 esophagus Anatomy 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 210000004761 scalp Anatomy 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 206010061245 Internal injury Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 208000012641 Pigmentation disease Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000003782 Raynaud disease Diseases 0.000 description 2
- 208000012322 Raynaud phenomenon Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 206010040844 Skin exfoliation Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 238000003723 Smelting Methods 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 210000000589 cicatrix Anatomy 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000035618 desquamation Effects 0.000 description 2
- 208000013219 diaphoresis Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000004761 fibrosis Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 230000009325 pulmonary function Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 201000005404 rubella Diseases 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 244000296912 Ageratum conyzoides Species 0.000 description 1
- 235000004405 Ageratum conyzoides Nutrition 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 235000016535 Capraria biflora Nutrition 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001299895 Microsporum ferrugineum Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 206010036030 Polyarthritis Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010040799 Skin atrophy Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 241001480048 Trichophyton tonsurans Species 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003460 anti-nuclear Effects 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 210000002230 centromere Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 201000010251 cutis laxa Diseases 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 108010074605 gamma-Globulins Proteins 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 150000002333 glycines Chemical class 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 210000004755 lingual frenum Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 208000030428 polyarticular arthritis Diseases 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000007390 skin biopsy Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000002037 soft tissue calcification Effects 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 210000005070 sphincter Anatomy 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- -1 sublimed preparation Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese patent medicine for treating tinea capitis, and belongs to the technical field of the treatment of skin diseases. In the technical scheme, the Chinese patent medicine is prepared from the following medicaments in part by weight: 60 to 70 parts of honeysuckle flower, 20 to 30 parts of root of red-rooted salvia, 15 to 25 parts of white paeony root, 15 to 25 parts of dwarf lilyturf tuber, 18 to 25 parts of adenophora root, 20 to 30 parts of liquoric root, 10 to 20 parts of stiff silkworm, 10 to 20 parts of schizonepeta spike, 15 to 25 parts of chaff flower root, 10 to 20 parts of clematis root, 10 to 20 parts of Himalayan teasel root, 20 to 30 parts of rehmannia root, 5 to 10 parts of cassia twig, 10 to 20 parts of baical skullcap root, 30 to 40 parts of raw tuber fleeceflower root, 15 to 25 parts of suberect spatholobus stem, 10 to 20 parts of common ducksmeat herb, 15 to 25 parts of red paeony root, 10 to 20 parts of Indian buead and 15 to 25 parts of motherwort fruit. Compared with the prior art, the Chinese patent medicine has the substantial characteristics and obvious advantages of eliminating diseases of patients, promoting physical and psychological health, along with convenience for administration, quick response and no side effect.
Description
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of tinea capitis, belong to TCM Dermatology treatment technology field.
Background technology
Tinea capitis is the mycotic infection of superficial part of scalp and hair, is divided into three kinds of tinea favosa, tinea alba and black dot tinea according to pathogen and clinical manifestation different.The traditional Chinese medical science is thought: from the beginning of the heresy retardance skin that mostly is rheumatic fever, or the neck hyperhidrosis, due to the stiffened cloth friction etc.; The sick impairment of YIN of consumption for a long time liquid, nutrient QI and blood being insufficient, wind syndrome due to blood-deficiency is given birth to dry, and failure of skin and muscle to be nourished forms; Blood-deficiency leading to hyperactivity of the liver, feelings will is unsuccessful, and is gloomy easypro, or nervous tired, flaming up of heart-fire, so that QI-blood circulation dereliction of duty, the skin that stagnates, the easy key factor that becomes to bring out, and pathogenic feelings are shown effect repeatedly.In a word, feelings will internal injury, ailment said due to cold or exposure invasion and attack are risk factors of primary disease morbidity, and nutrient blood is become estranged, passages through which vital energy circulates loses and dredges, coagulation of QI-blood then is its pathogenesis.Though tinea capitis does not directly influence life, still influence people's aesthetic feeling and physical and mental health.
At present, the medicine of treatment tinea capitis disease has Chinese medicine, Western medicine, but curative effect does not all make patient satisfaction.According to pathogenic factor, the pathological change of tinea capitis, through investigation in many ways, textual criticism repeatedly, scientific validation learns that the reason that causes tinea capitis mainly is harmful product of body metabolism, be impregnated between blood cell in the matter, cause the human body environment pollution, the change of the pure matter of blood.Heat in blood, dry, the blood stasis of blood occur, accumulate stagnant resistance and too much cause pestilent toxicity to be sent out in skin.With the passing of time hematozemia wound essence is delayed in outbreak repeatedly all the year round, the course of disease, failure of skin and muscle to be nourished, and uninteresting pruritus, health is wrecked in the insomnia of overtaxing one's nerves.
The inducement of tinea capitis mostly is Nervous and Mental Factors, and owing to feelings will internal injury, ailment said due to cold or exposure invasion and attack are risk factors of primary disease morbidity, nutrient blood is become estranged, passages through which vital energy circulates loses and dredges, coagulation of QI-blood then is its pathogenesis.Though tinea capitis does not directly influence life, still influence people's aesthetic feeling and physical and mental health.
Summary of the invention
Technical problem to be solved by this invention provides a kind of to eliminate patient's illness, promotion physical and mental health, the Chinese patent medicine that has the treatment tinea capitis that the patient takes medicine conveniently, curative effect is fast, have no side effect simultaneously.
For solving the problems of the technologies described above, the present invention adopts following technical scheme: a kind of Chinese patent medicine for the treatment of tinea capitis is characterized in that being formed by the medication preparation of following weight parts: 50 1 80 parts of Flos Loniceraes, 10 1 40 parts of Radix Salviae Miltiorrhizaes, 10 1 30 parts of the Radix Paeoniae Albas, 10 1 30 parts of Radix Ophiopogonis, 15 1 30 parts of Radix Adenophorae (Radix Glehniae), 10 1 40 parts in Radix Glycyrrhizae, 5 one 25 parts of Bombyx Batryticatus, 5 one 25 parts of mustard fringes, 10 1 30 parts of Radix Achyranthis Bidentataes, 5 one 25 parts of Radix Clematidis, 5 one 25 parts of Radix Dipsacis, 10 1 40 parts in the Radix Rehmanniae, 5 one 15 parts of Ramulus Cinnamomi, 5 one 25 parts of Radix Scutellariaes are given birth to 20 1 50 parts of first birds, 10 1 30 parts of Caulis Spatholobis, 5 one 25 parts in Herba Spirodelae, 10 1 30 parts of Radix Paeoniae Rubra, 5 one 25 parts in Poria, 10 1 30 parts of Fructus Leonuris.
The preferred version of above-mentioned medicaments in part by weight is: 60 1 70 parts of Flos Loniceraes, 20 1 30 parts of Radix Salviae Miltiorrhizaes, 15 1 25 parts of the Radix Paeoniae Albas, 15 1 25 parts of Radix Ophiopogonis, 18 1 25 parts of Radix Adenophorae (Radix Glehniae), 20 1 30 parts in Radix Glycyrrhizae, 10 1 20 parts of Bombyx Batryticatus, 10 1 20 parts of mustard fringes, 15 1 25 parts of Radix Achyranthis Bidentataes, 10 1 20 parts of Radix Clematidis, 10 1 20 parts of Radix Dipsacis, 20 1 30 parts in the Radix Rehmanniae, 5 one 10 parts of Ramulus Cinnamomi, 10 1 20 parts of Radix Scutellariaes are given birth to 30 1 40 parts of first birds, 15 1 25 parts of Caulis Spatholobis, 10 1 20 parts in Herba Spirodelae, 15 1 25 parts of Radix Paeoniae Rubra, 10 1 20 parts in Poria, 15 1 25 parts of Fructus Leonuris.
The preferred plan of above-mentioned medicaments in part by weight is: 65 parts of Flos Loniceraes, 25 parts of Radix Salviae Miltiorrhizaes, 20 parts of the Radix Paeoniae Albas, 20 parts of Radix Ophiopogonis, 20 parts of Radix Adenophorae (Radix Glehniae), 25 parts in Radix Glycyrrhizae, 15 parts of Bombyx Batryticatus, 15 parts of mustard fringes, 20 parts of Radix Achyranthis Bidentataes, 15 parts of Radix Clematidis, 15 parts of Radix Dipsacis, 25 parts in the Radix Rehmanniae, 8 parts of Ramulus Cinnamomi, 15 parts of Radix Scutellariaes, give birth to 35 parts of first birds, 20 parts of Caulis Spatholobis, 15 parts in Herba Spirodelae, 20 parts of Radix Paeoniae Rubra, 15 parts in Poria, 20 parts of Fructus Leonuris.
Above-mentioned described Chinese patent medicine is made pill, sublimed preparation, powder, tablet, unguentum, decoction and the different oral medicine dosage form of capsule dress powder according to the conventional technology of preparing of Chinese medicine.
Above-mentioned described Chinese patent medicine also contains drug excipient.
The principles of formulating prescriptions of Chinese patent medicine of the present invention are: nourish liver spleen, replenishing QI to invigorate the spleen, nourshing blood and promoting blood circulation, dredge the meridian passage, blood circulation promoting and blood stasis dispelling, set upright and get rid of evils, regulate immunologic function, improve skin microcirculation, reach the purpose of treatment tinea capitis.The present invention has proper, the reasonable recipe of compatibility of drugs, and the effect of its described each herbal medicine is:
Flos Lonicerae: sweet in the mouth, cold in nature.Return lung, the stomach warp.Effect cures mainly: heat-clearing and toxic substances removing, epidemic febrile disease heating, toxic-heat and blood stasis, carbuncle furuncle, sore throat and multiple infectious disease.
Radix Salviae Miltiorrhizae: bitter in the mouth, little suffering, cold nature; Go into the heart, spleen, liver, kidney footpath; Effect: have blood circulation promoting and blood stasis dispelling, nourishing blood to tranquillize the mind, removing heat from blood repercussive effect; Cure mainly: blood stasis head, breast, the side of body, abdomen pain, gather, menoxenia, the dysmenorrhea amenorrhea, the stasis of blood stagnated and suffered from abdominal pain puerperal, arthralgia, the traumatic injury congestive edema, epidemic febrile disease is vexed, palpitation due to deficiency of blood, sore swollen toxin, red rash scabies.
The Radix Paeoniae Alba: bitter in the mouth, acid, cold nature.Main smelting: menoxenia, abdominal pain during menstruation, metrorrhagia, spontaneous perspiration, night sweat, side of body rib epigastric pain, limb pain twin, headache, dizzy.
Radix Ophiopogonis: sweet, little hardship is slightly cold.GUIXIN, lung, stomach warp.Effect: YIN nourishing and the production of body fluid promoting, lung moistening clears away heart-fire.Be used for dryness of the lung dry cough, the chronic consumptive disease cough, Tianjin wound is thirsty, vexed insomnia, interior-heat is quenched one's thirst, dryness of the intestine constipation, pharyngeal diphtheria.
Radix Adenophorae (Radix Glehniae): sweet in the mouth, little hardship; Cold nature.Gui Jing: return lung, the stomach warp.Function cures mainly: replenishing YIN and removing heat, moistening the lung and resolving phlegm, reinforcing stomach reg fluid.Main deficiency of YIN chronic cough, the consumptive disease expectorant blood of coughing, cough caused by dryness expectorant is few, the deficiency-heat sore throat, Tianjin wound is thirsty.
Radix Dipsaci: bitter in the mouth, sweet, hot, slightly warm in nature; Return liver, kidney channel.Function master's smelting: invigorating the liver and kidney, reuniting the fractured tendons and bones, blood circulation regulating.Control aching pain in waist and back, the foot and knee being feeble, vaginal bleeding during pregnancy, metrorrhagia, leukorrhagia, seminal emission, traumatic injury, incised wound, anal fistula, the carbuncle skin ulcer is swollen.
Radix Glycyrrhizae: sweet in the mouth, property is flat; Return 12 warps.Effect: detoxifcation is arranged, eliminate the phlegm, pain relieving, spasmolytic be so that pharmacological action such as anticancer.On the traditional Chinese medical science, the Radix Glycyrrhizae invigorating the spleen and replenishing QI is grown and to be coughed lung moistening, and the emergency detoxifcation is in harmonious proportion hundred medicines.The clinical practice branch " is given birth to and uses " with " processed with honey " not.Give birth to curing mainly laryngopharynx swelling and pain cellulitis skin infection, gastrointestinal ulceration and separate poison of drug, alimentary toxicosis etc.; Processed with honey cures mainly spleen and stomach function and goes down, and big loose stool is thin, weak heating and cough, cardiopalmus etc.
Bombyx Batryticatus: acrid in the mouth is salty, and property is flat.Effect: expelling wind to relieve convulsion, dissipating phlegm and resolving masses.Control apoplectic aphasia, infantile convulsion, wind syndrome of head, acute throat trouble.Sore throat, scrofula tuberculosis.Wind skin ulcer urticaria, erysipelas, mastitis.
Mustard fringe: acrid in the mouth, slightly warm in nature.Return lung, Liver Channel.Effect is used: deliver diffusing wind, the rash skin ulcer that disappears, hemostasis (parch to black).Cure mainly flu, the headache, the wind heat conjunctival congestion, measles without adequate eruption, the rubella pruritus, skin infection from the beginning of, metrostaxis, the hemorrhoidal bleeding of having blood in stool, puerperal blood faints.
Radix Achyranthis Bidentatae: bitter in the mouth, acid, property is flat.Return liver, kidney channel.Effect: invigorating the liver and kidney; Bone and muscle strengthening; Promoting blood circulation to restore menstrual flow; Ignite (blood) descending; Inducing diuresis for treating stranguria syndrome.Cure mainly: soreness of waist and knee joint; Flaccidity and weakness of the lower limbs; Amenorrhea due to stagnation of blood; Dysmenorrhea; Puerperal abdominal pain due to blood stasis; Lump in the abdomen; Retention of placenta; Pyretic stranguria; Stranguria with blood; Traumatic injury; The carbuncle malignant boil; Laryngopharynx swelling and pain.
Radix Clematidis: acrid in the mouth, salty, warm in nature.Go into to return urinary bladder channel.Effect: wind-damp dispelling, removing obstruction in the collateral to relieve pain, a fishbone or other bone caught in the throat that disappears, rheumatic Bi syndrome.The hot temperature of loosing of this product is logical, and property is apt to away suddenly, and current 12 warps can wind-damp dispelling, again can the meridian dredging and pain relieving is dispelling the wind and dampness pathogens arthralgia pain key medicine.
The Radix Rehmanniae: another name: Radix Rehmanniae, marrow, smart, the benzyl root of sun, be goatweed.The property flat, bitter in the mouth, be used as medicine with ratan on the Chinese medicine, function heat-clearing and toxic substances removing, promoting blood circulation to restore menstrual flow cure mainly diseases such as arthralgia.
Ramulus Cinnamomi: acrid in the mouth, sweet, warm in nature.Efficacy effect: diaphoresis expelling pathogenic factors from muscles, warming the meridian and promoting blood circulation.Control exterior syndrome due to wind-cold, shoulder back of the body podomere ache, thoracic obstruction phlegm retention, amenorrhea and mass in the abdomen.
Radix Scutellariae: bitter in the mouth, cold in nature.Return lung, gallbladder, spleen, large intestine, small intestine meridian.Function cures mainly: heat clearing and damp drying, and eliminating fire and detoxication, hemostasis, antiabortive.Be used for hygropyrexia, fever disease in summer vomiting and nausea uncomfortable in chest, damp and hot feeling of fullness, dysentery, jaundice, the cough due to lung-heat, the hyperpyrexia excessive thirst, heat in blood is told nosebleed, carbuncle sore tumefacting virus, frequent fetal movement.
Give birth to first bird: sweet in the mouth, hardship, property is flat.GUIXIN, liver, large intestine channel.Function: detoxifcation, eliminating carbuncle, loosening bowel to relieve constipation are usually used in treating scrofula carbuncle sore, rubella pruritus, dryness of the intestine constipation; Liver and kidney tonifying, benefiting essence-blood, strengthening bone and muscle, defying age improves body immunity.
Caulis Spatholobi: bitter in the mouth, sweet, warm in nature.Return liver, kidney channel.Function cures mainly: enrich blood, invigorate blood circulation, collateral dredging.Be used for menoxenia, blood deficiency and yellow complexion, paralysis and numbness, rheumatic arthralgia.
Herba Spirodelae: acrid in the mouth, cold in nature.Nontoxic.Go into lung, liver, spleen channel.Effect: diaphoresis, dispel the wind row water, heat clearing away, detoxifcation.Cure mainly: the hot carbuncle of row when controlling, macule is not saturating, wind heat pain rash, skin pruritus, edema, amenorrhea, the skin ulcer tinea, erysipelas is scalded.
Radix Paeoniae Rubra: sour in the mouth, hardship, cool in nature.Go into liver, spleen channel.Effect: clots absorbing, pain relieving, removing heat from blood, detumescence.Cure mainly: control the stagnant amenorrhea of the stasis of blood, the hernia abdominal mass is gathered, stomachache, hypochondriac pain, epistaxis, dysentery, discharging fresh blood stool, conjunctival congestion, carbuncle.
Poria: the property slightly sweet flavor is flat, goes into the heart, lung, spleen channel.Has eliminating dampness and diuresis, invigorating the spleen and regulating the stomach, the effect of mind tranquilizing and the heart calming.Can control dysuria, edema distension, phlegm retention cough with dyspnea, vomiting, malignant histocytosis, effect such as have loose bowels.
Fructus Leonuri: be the fruit of labiate Herba Leonuri.Sweet in the mouth, suffering; Cold nature; GUIXIN bag, Liver Channel.Effect: menoxenia, dysmenorrhea, amenorrhea, the stasis of blood stagnated and suffered from abdominal pain puerperal, the liver-heat headache, dizziness, conjunctival congestion and swelling pain, order is given birth to cataracta.
The present invention follows the principles of formulating prescriptions of the traditional Chinese medical science " monarch ", and all compositions come from the medicine that China's " pharmacopeia " records, all medicines mutually and, has temperature compensation liver spleen, the wind dehumidifying of loosing, QI and blood regulating, is set upright and is got rid of evils dredge the meridian passage, blood circulation promoting and blood stasis dispelling, regulate immunologic function, improve skin microcirculation, reach treatment and prevention tinea capitis, curative effect is showing, have no side effect various Chinese medicine preparation taking conveniences.
The clinical use result of Chinese patent medicine of the present invention shows to have following advantage:
1, the Chinese medicine each component selected for use of the present invention meets the regulation of The Drug Administration Law of People's Republic of China, utilizes the comprehensive function treatment and the prevention tinea capitis of the Chinese medicine of respectively distinguishing the flavor of, and is nontoxic to human body.Acute toxicity test and accumulation toxicity test through white mice and rat show that underproof animal does not see any toxic reaction, compare zero difference through anatomic observation hemogram, liver function, each organs and tissues morphology finding and matched group, prove that its safety of medicine is reliable.
2, rich in proteins, glucose, glucuronic acid, volatile oil, pectin, fructose, organic acid, lecithin, vitamin, aminoacid in the Chinese patent medicine preparation of the present invention, also contain various trace elements such as Saponin, plant sterol, calcium, help absorption of human body, health invigorating, taking convenience.
3, Chinese patent medicine preparation of the present invention not only can effectively be treated tinea capitis, and it is also very obvious to this sick preventive effect, particularly by working in coordination with mutually between the medicine, strengthen medicine and treat characteristic separately, by dredge the meridian passage and adjusting immunologic function, improve the intrinsic healthy energy of patient body and physical and mental health and life quality, reached the healing rehabilitation efficacy preferably.
Further specify the therapeutic effect of patent medicine of the present invention below by the clinical practice example to the treatment tinea capitis.
One, clinical diagnosis standard:
Diagnosis basis: tinea capitis is divided into three kinds of tinea alba, tinea favosa and black dot tinea usually.1, the typical skin lesion performance of various tinea capitis; Tinea favosa: be commonly called as " tinea alba " or " leprosy dysentery head " (1) and send out well in the child, the adult also can infect; (2) typical skin lesion is the scutulum of plate-like Semen Glycines size, and the center has hair to run through, and more the back forms atrophic cicatrix; (3) disease is sent out uneven, and is withered matt, permanent alopecia.Tinea alba (1) is mainly seen in the typical skin lesion of child (2) for just sending out bigger squama sexupara speckle, the less satellite shape speckle of secondary on every side, spontaneous recovery after the adolescence, more back preventing from scar; (3) the sick Zhou Bianbai of sending out overlaps, and often fractures apart from scalp 2-3mm place.Black dot tinea (1) is good to be sent out in the child, and the adult also can infect; (2) typical skin lesion is that majority is dispersed in the squama stigma, and healing can have the small pieces cicatrix; (3) sick sending out just gone out scalp and promptly fractureed, and stump is point-like darkly.2, the disease of various tinea capitis is sent out characteristics; Tinea favosa is mainly in the child, and the adult also can infect; Tinea alba mainly is that the child falls ill; The black dot tinea child can infect with becoming per capita.3, sickly send out the direct microscopy of fungus and cultivate positive: (1) tinea favosa, microscopy are the endothrix silk, and scutulum intrinsic articulation spore or favic chandelier are cultivated and be achorion; (2) tinea alba: microscopy is the endothrix silk, sends out the outer ring hole
Support and be Canis familiaris L. pityrosporion ovale or Microsporum ferrugineum; (3) black dot tinea: microscopy is chain spore in sending out, and cultivates to be purple tinea bacterium or trichophyton tonsurans.5. filter the Burdick lamp inspection.(1) tinea favosa: dirty-green fluorescence; (2) tinea alba: bright green fluorescence; (3) black dot tinea: no fluorescence.
Differential Diagnosis:
The distribution of tinea capitis is many also to be had in the head central distribution along the root of hair edge, not of uniform size, local pruritus, and surperficial squama is mixed with the pale red semitransparent thin film, and the form of tinea mostly is drop shape, coin shape or plate-like, map shape etc.Onset slowly enlarges in a certain position of head, finally involves big portion or whole, damages to be erythema, and vesicle, squama and keratinization thicken, and should consider to be diagnosed as tinea capitis, and the fungus inspection positive can be made a definite diagnosis.
Every 1 main standard or 2 minor criterias are diagnosable, and other help the performance diagnosed: Raynaud phenomenon, and polyarthritis or arthralgia, esophageal peristalsis is unusual, swelling of dermatopathology collagen fiber and fibrosis.
The tinea capitis syndrome, 3 of concrete wherein 5 symptoms, or it is diagnosable to add the centromere antibody positive more than 3.
Early diagnosis
(1) clinical manifestation: 1. Raynaud phenomenon; 2. the dry and cracked desquamation of pachylosis; 3. arthralgia/arthritis.
(2) esophagus function: 1. efflux time prolongs; 2. esophageal sphincter pressure and distal esophagus are swallowed drops.
(3) pulmonary function: 1. diffusion goes down; 2. forced expiratory flow during middle half of the FVC slows down; 3. the residual gas closing volume CV increases.
(4) lab testing: rheumatoid factor (RF) positive, antinuclear antibody (ANA) positive, gamma globulin increases, and the visible collagen fiber of skin biopsy expand and fibrosis.
(5) with reference to symptom: 1. women; 2. irregular heating; 3. lingual frenum significantly shortens; 4. diffusivity pigmentation; 5. face, neck and palm are the multiple telangiectasis of speckle shape; 6. skin soft tissue calcification, redness, desquamation.
Determine diagnosis
Possess have at least in the clinical symptoms two and esophagus and or abnormal pulmonary function in two above persons.
May diagnose and possess 3 above persons in 5.Need tracing study or further examiner: possess 2 persons in 5.
Two, case selection
The sickness rate of tinea capitis is region-by-region, ethnic group and the colour of skin not.This disease is all arranged all over the world, and M-F about equally.Put down in writing according to interrelated data: age of onset is in the majority in 5 one 55 years old, accounts for 80% of sum, and for this reason, case selection is whole cases totally 38 examples with door rash prescription on individual diagnosis patient, diagnoses according to " clinical diagnosis standard ": tinea alba 13 examples, tinea favosa 16 examples, black dot tinea 9 examples.
Three. curative effect determinate standard
Classification is mainly carried out according to the change of clinical symptoms and sign in various places at present, is divided into 4 grades substantially.
Be almost recovered: skin lesion is most of to recover normal, only stays mild skin atrophy or pigmentation, dermatolysis, softness, and the decortication phenomenon disappears; The precious ulcer healing of speckle, the clinical internal organs infringement symptom of following disappears substantially.
Produce effects: skin lesion recovers more than 50% normally, skin erythema and the basic disappearance of the pain of itching, and clinical symptoms obviously alleviates, big recovery of function.
Effectively: skin lesion is slightly better, and red swelling of the skin, speckle treasure, decortication alleviate, and damage range is dwindled, the commentaries on classics of getting better slightly of symptom and sign.
Invalid: treated 3 months, skin blister, squama, the symptom of festering are not got better changes or skin lesion continuation expansion, and viscera function does not recover or damages and increase the weight of.
Four, clinical application method and therapeutic outcome
1, clinical application method
According to the scope and the distribution situation of patient's sick time, the cause of disease and tinea capitis, the component medication:
Take the tablet of embodiment 4, each 5-10 gram, every day 3-4 time, warm water delivery service, take half an hour ante cibum.One month is a course of treatment, take continuously three the course of treatment observe the curative effect.
2, therapeutic outcome
Amount to 42 examples through clinical diagnosis treatment tinea capitis patient, male's 24 examples, women's 18 examples, the age is 8-55 year.15 examples that are almost recovered among the 42 routine patients account for 36%, and produce effects 16 examples account for 38%, and effective 8 examples account for 19%, and invalid 3 examples account for 7%, and total effective rate reaches 93%.After treatment, the red and swollen vesicle of patient skin, squama decortication, the painful phenomenon alleviation of itching of festering, clinical symptoms obviously alleviates, big recovery of function, and patient does not have any untoward reaction, and three big routine tests and hepatic and renal function and the detection of internal organs infringement symptom are not found any unusual.Fully recover through the patient and to pay a return visit statistics, do not see an example recurrence so far.
The specific embodiment
Embodiment 1
Press the row weight portion and take by weighing each Chinese crude drug:
50 parts of Flos Loniceraes, Radix Salviae Miltiorrhizae 10,5 parts of mustard fringes, 10 parts of Radix Achyranthis Bidentataes, 5 parts of Radix Clematidis, 5 parts of Radix Dipsacis, 10 parts in the Radix Rehmanniae, 5 parts of Ramulus Cinnamomi, 5 parts of Radix Scutellariaes are given birth to 20 parts of first birds, 10 parts of Caulis Spatholobis, 5 parts in Herba Spirodelae, 10 parts of Radix Paeoniae Rubra, 5 parts in Poria, 10 parts of Fructus Leonuris.The preparation technology of present embodiment is: above-mentioned each medicinal raw material is made sublimed preparation according to the pharmaceutical methods that routine prepares sublimed preparation.
Embodiment 2
Press the row weight portion and take by weighing each medical material:
80 parts of Flos Loniceraes, 40 parts of Radix Salviae Miltiorrhizaes, 30 parts of the Radix Paeoniae Albas, 30 parts of Radix Ophiopogonis, 30 parts of Radix Adenophorae (Radix Glehniae), 40 parts in Radix Glycyrrhizae, 25 parts of Bombyx Batryticatus, 25 parts of mustard fringes, 0 part of Radix Achyranthis Bidentatae, 25 parts of Radix Clematidis, 25 parts of Radix Dipsacis, 40 parts in the Radix Rehmanniae, 15 parts of Ramulus Cinnamomi, 25 parts of Radix Scutellariaes, give birth to 50 parts of first birds, 30 parts of Caulis Spatholobis, 25 parts in Herba Spirodelae, 30 parts of Radix Paeoniae Rubra, 25 parts in Poria, 30 parts of Fructus Leonuris.
The preparation technology of present embodiment is: above-mentioned each medicinal raw material is made packed powder according to the pharmaceutical methods that routine prepares powder.
Embodiment 3
Press the row weight portion and take by weighing each medical material: 60 parts of Flos Loniceraes, 20 parts of Radix Salviae Miltiorrhizaes, 15 parts of the Radix Paeoniae Albas, 15 parts of Radix Ophiopogonis, 18 parts of Radix Adenophorae (Radix Glehniae), 20 parts in Radix Glycyrrhizae, 10 parts of Bombyx Batryticatus, 10 parts of mustard fringes, 15 parts of Radix Achyranthis Bidentataes, 10 parts of Radix Clematidis, 10 parts of Radix Dipsacis, 20 parts in the Radix Rehmanniae, 5 parts of Ramulus Cinnamomi, 10 parts of Radix Scutellariaes, give birth to 30 parts of first birds, 15 parts of Caulis Spatholobis, 10 parts in Herba Spirodelae, 15 parts of Radix Paeoniae Rubra, 10 parts in Poria, 15 parts of Fructus Leonuris.
The preparation technology of present embodiment is: above-mentioned each medicinal raw material is made capsule according to the pharmaceutical methods that routine prepares capsule.
Embodiment 4
Press the row weight portion and take by weighing each medical material: 70 parts of Flos Loniceraes, 30 parts of Radix Salviae Miltiorrhizaes, 25 parts of the Radix Paeoniae Albas, 25 parts of Radix Ophiopogonis, 25 parts of Radix Adenophorae (Radix Glehniae), 30 parts in Radix Glycyrrhizae, 20 parts of Bombyx Batryticatus, 20 parts of mustard fringes, 25 parts of Radix Achyranthis Bidentataes, 20 parts of Radix Clematidis, 20 parts of Radix Dipsacis, 30 parts in the Radix Rehmanniae, 10 parts of Ramulus Cinnamomi, 20 parts of Radix Scutellariaes, give birth to 40 parts of first birds, 25 parts of Caulis Spatholobis, 20 parts in Herba Spirodelae, 25 parts of Radix Paeoniae Rubra, 20 parts in Poria, 25 parts of Fructus Leonuris.
The preparation technology of present embodiment is: above-mentioned each medicinal raw material is made tablet according to the pharmaceutical methods that routine prepares tablet, (as conventional tablet, sugar coated tablet, film coated tablet etc.), and give conventional drug excipient (as starch, sucrose, lactose, calcium stearate, magnesium stearate etc.).
Embodiment 5
Press the row weight portion and take by weighing each medical material: 65 parts of Flos Loniceraes, 25 parts of Radix Salviae Miltiorrhizaes, 20 parts of the Radix Paeoniae Albas, 20 parts of Radix Ophiopogonis, 20 parts of Radix Adenophorae (Radix Glehniae), 25 parts in Radix Glycyrrhizae, 15 parts of Bombyx Batryticatus, 15 parts of mustard fringes, 20 parts of Radix Achyranthis Bidentataes, 15 parts of Radix Clematidis, 15 parts of Radix Dipsacis, 8 parts of 25 parts of Ramulus Cinnamomi of the Radix Rehmanniae, 15 parts of Radix Scutellariaes, give birth to 35 parts of first birds, 20 parts of Caulis Spatholobis, 15 parts in Herba Spirodelae, 20 parts of Radix Paeoniae Rubra, 15 parts in Poria, 20 parts of Fructus Leonuris.
The preparation technology of present embodiment is: above-mentioned each medicinal raw material is made pill according to the pharmaceutical methods that routine prepares pill, and give conventional drug excipient.
Embodiment 6
Press the row weight portion and take by weighing each medical material: 60 parts of Flos Loniceraes, 23 parts of Radix Salviae Miltiorrhizaes, 22 parts of the Radix Paeoniae Albas, 22 parts of Radix Ophiopogonis, 22 parts of Radix Adenophorae (Radix Glehniae), 25 parts in Radix Glycyrrhizae, 15 parts of Bombyx Batryticatus, 15 parts of mustard fringes, 20 parts of Radix Achyranthis Bidentataes, 15 parts of Radix Clematidis, 15 parts of Radix Dipsacis, 25 parts in the Radix Rehmanniae, 8 parts of Ramulus Cinnamomi, 15 parts of Radix Scutellariaes, give birth to 30 parts of first birds, 22 parts of Caulis Spatholobis, 12 parts in Herba Spirodelae, 20 parts of Radix Paeoniae Rubra, 15 parts in Poria, 20 parts of Fructus Leonuris.
The preparation technology of present embodiment is: above-mentioned each medicinal raw material is made granule according to the pharmaceutical methods that routine prepares granule.
Claims (5)
1. a Chinese patent medicine for the treatment of tinea capitis is characterized in that being formed by the medication preparation of following weight parts: 50 1 80 parts of Flos Loniceraes, 10 1 40 parts of Radix Salviae Miltiorrhizaes, 10 1 30 parts of the Radix Paeoniae Albas, 10 1 30 parts of Radix Ophiopogonis, 12 1 35 parts of Radix Adenophorae (Radix Glehniae), 10 1 40 parts in Radix Glycyrrhizae, 5 one 25 parts of Bombyx Batryticatus, 5 one 25 parts of mustard fringes, 10 1 30 parts of Radix Achyranthis Bidentataes, 5 one 25 parts of Radix Clematidis, 5 one 25 parts of Radix Dipsacis, 10 1 40 parts in the Radix Rehmanniae, 5 one 15 parts of Ramulus Cinnamomi, 5 one 25 parts of Radix Scutellariaes, give birth to 20 1 50 parts of first birds, 1 one 30 parts of Caulis Spatholobis, 5 one 25 parts in Herba Spirodelae, 10 1 30 parts of Radix Paeoniae Rubra, 5 one 25 parts in Poria, 10 1 30 parts of Fructus Leonuris.
2. according to the Chinese patent medicine of the described treatment tinea capitis of claim 1, it is characterized in that forming: 60 1 70 parts of Flos Loniceraes, 20 1 30 parts of Radix Salviae Miltiorrhizaes by the medication preparation of following weight parts, 15 1 25 parts of the Radix Paeoniae Albas, 15 1 25 parts of Radix Ophiopogonis, 18 1 25 parts of Radix Adenophorae (Radix Glehniae), 20 1 30 parts in Radix Glycyrrhizae, 10 1 20 parts of Bombyx Batryticatus, 10 1 20 parts of mustard fringes, 15 1 25 parts of Radix Achyranthis Bidentataes, 10 1 20 parts of Radix Clematidis, 10 1 20 parts of Radix Dipsacis, 20 1 30 parts in the Radix Rehmanniae, 5 one 10 parts of Ramulus Cinnamomi, 10 1 20 parts of Radix Scutellariaes, give birth to 30 1 40 parts of first birds, 15 1 25 parts of Caulis Spatholobis, 10 1 20 parts in Herba Spirodelae, 15 1 25 parts of Radix Paeoniae Rubra, 10 1 20 parts in Poria, 15 1 25 parts of Fructus Leonuris.
3. according to the Chinese patent medicine of the described treatment tinea capitis of claim 1, it is characterized in that forming: 60 parts of Flos Loniceraes, 25 parts of Radix Salviae Miltiorrhizaes, 20 parts of the Radix Paeoniae Albas by the medication preparation of following weight parts, 20 parts of Radix Ophiopogonis, 21 parts of Radix Adenophorae (Radix Glehniae), 25 parts in Radix Glycyrrhizae, 15 parts of Bombyx Batryticatus, 15 parts of mustard fringes, 20 parts of Radix Achyranthis Bidentataes, 15 parts of Radix Clematidis, 15 parts of Radix Dipsacis, 25 parts in the Radix Rehmanniae, 8 parts of Ramulus Cinnamomi, 15 parts of Radix Scutellariaes, give birth to 35 parts of first birds, 20 parts of Caulis Spatholobis, 15 parts in Herba Spirodelae, 20 parts of Radix Paeoniae Rubra, 15 parts in Poria, 20 parts of Fructus Leonuris.
4. according to the Chinese patent medicine of the described treatment tinea capitis of arbitrary claim in the claim 1 to 3, it is characterized in that described Chinese patent medicine makes pill, powder, tablet, unguentum, decoction or the different oral medicine dosage form of capsule dress powder according to the conventional technology of preparing of Chinese medicine.
5. the sclerodermatous Chinese patent medicine of treatment according to claim 4 is characterized in that described Chinese patent medicine also contains drug excipient.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011101565922A CN102228613B (en) | 2011-05-31 | 2011-05-31 | Chinese patent medicine for treating tinea capitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011101565922A CN102228613B (en) | 2011-05-31 | 2011-05-31 | Chinese patent medicine for treating tinea capitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102228613A true CN102228613A (en) | 2011-11-02 |
| CN102228613B CN102228613B (en) | 2012-11-14 |
Family
ID=44841245
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011101565922A Active CN102228613B (en) | 2011-05-31 | 2011-05-31 | Chinese patent medicine for treating tinea capitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102228613B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103251850A (en) * | 2013-05-24 | 2013-08-21 | 苏州谷力生物科技有限公司 | Traditional Chinese medicine mixture for treating psoriasis |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1222344A (en) * | 1998-01-09 | 1999-07-14 | 张天福 | Chinese medicinal shampoo of natural plant ingredients |
| CN1473588A (en) * | 2003-05-26 | 2004-02-11 | 雷 王 | Chinese medicine of capsule (tablet) of nine ingredients for treating psoriasis and its preparing process |
| CN1485058A (en) * | 2002-09-23 | 2004-03-31 | 姜宏涛 | Psoriasis-treating composition |
| CN1711864A (en) * | 2004-06-25 | 2005-12-28 | 黄世杰 | Herbal tea beverage for treating skin diseases and production thereof |
| CN101274093A (en) * | 2008-05-06 | 2008-10-01 | 广冬云 | Chinese medicine for curing fungal dermatopathy |
| CN101518600A (en) * | 2009-03-30 | 2009-09-02 | 李燕 | Chinese medicinal composition for treating bacterial or fungal dermatosis and preparation method thereof |
-
2011
- 2011-05-31 CN CN2011101565922A patent/CN102228613B/en active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1222344A (en) * | 1998-01-09 | 1999-07-14 | 张天福 | Chinese medicinal shampoo of natural plant ingredients |
| CN1485058A (en) * | 2002-09-23 | 2004-03-31 | 姜宏涛 | Psoriasis-treating composition |
| CN1473588A (en) * | 2003-05-26 | 2004-02-11 | 雷 王 | Chinese medicine of capsule (tablet) of nine ingredients for treating psoriasis and its preparing process |
| CN1711864A (en) * | 2004-06-25 | 2005-12-28 | 黄世杰 | Herbal tea beverage for treating skin diseases and production thereof |
| CN101274093A (en) * | 2008-05-06 | 2008-10-01 | 广冬云 | Chinese medicine for curing fungal dermatopathy |
| CN101518600A (en) * | 2009-03-30 | 2009-09-02 | 李燕 | Chinese medicinal composition for treating bacterial or fungal dermatosis and preparation method thereof |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103251850A (en) * | 2013-05-24 | 2013-08-21 | 苏州谷力生物科技有限公司 | Traditional Chinese medicine mixture for treating psoriasis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102228613B (en) | 2012-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101703698A (en) | Chinese medicament for treating heart disease | |
| CN102362950A (en) | Traditional Chinese medicine for treating leucoderma | |
| CN102362919B (en) | Traditional Chinese medicine for treating scleroderma | |
| CN102406867A (en) | Traditional Chinese medicine for treating psoriasis | |
| CN102362934A (en) | Chinese patent medicine for treating erythema nodosum | |
| CN102423433A (en) | Traditional Chinese drug mixture for treating psoriasis | |
| CN102406866A (en) | Chinese medicinal composition for treating psoriasis | |
| CN102579975B (en) | Traditional Chinese medicine mixture for treating psoriasis | |
| CN104784538A (en) | Chinese medicinal preparation for treating diabetes and preparation method | |
| CN102406865A (en) | Chinese medicinal composition for treating psoriasis | |
| CN102406893A (en) | Chinese patent medicine for treating psoriasis. | |
| CN102416117A (en) | Chinese patent medicine for treating psoriasis | |
| CN102228576B (en) | Chinese patent medicine for treating discoid lupus erythematosus | |
| CN102579895B (en) | Traditional Chinese medicine composition for treating psoriasis | |
| CN102228613B (en) | Chinese patent medicine for treating tinea capitis | |
| CN101366878A (en) | Traditional Chinese medicine for female acyesis and aphoria and preparation method thereof | |
| CN102362957B (en) | Chinese prepared medicine for treating deep lupus erythematosus | |
| CN102552824B (en) | Traditional Chinese medicine prepared prescription for treating psoriasis | |
| CN102423458A (en) | Chinese patent medicine for treating psoriasis | |
| CN102416099A (en) | Traditional Chinese medicine for treating psoriasis | |
| CN102228619B (en) | Chinese patent medicine for treating systemic lupus erythematosus | |
| CN101095922A (en) | Chinese traditional medicine composition for treating diabetes peripheral neuritis | |
| CN102362984B (en) | A Chinese patent medicine for curing toxic erythema | |
| CN102416118A (en) | Chinese medicinal composition for treating psoriasis | |
| CN105477472A (en) | Medicament for treating periodontitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: RUDONG TECHNOLOGY CENTER Free format text: FORMER OWNER: QU SHUMIN Effective date: 20131202 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 264000 YANTAI, SHANDONG PROVINCE TO: 226400 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20131202 Address after: 226400, friendship road, Nantong Town, Rudong County, Jiangsu, 66 Patentee after: Rudong science and Technology Center Address before: 264000 Yantai psoriasis research institute, 11 Wenhua Road, Zhifu District, Shandong, Yantai Patentee before: Qu Shumin |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20200706 Address after: No. 10, Fandi South Road, juegang Town, Rudong County, Nantong City, Jiangsu Province Patentee after: Rudong industrial and commercial information consulting service center Address before: 226400, friendship road, Nantong Town, Rudong County, Jiangsu, 66 Patentee before: Rudong science and Technology Center |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20210826 Address after: 226400 No.8, wisdom Avenue, Donghu scenic area, Dayu Town, Rudong County, Nantong City, Jiangsu Province Patentee after: Nantong Donghu International Travel Agency Co., Ltd Address before: 226400 No.10 Fandi South Road, juegang Town, Rudong County, Nantong City, Jiangsu Province Patentee before: Rudong industrial and commercial information consulting service center |
|
| TR01 | Transfer of patent right |